O fisioterapeuta e sua relação com o novo SARS-CoV-2 e com a COVID-19*
Physiotherapy and its relationship with the new SARS-CoV-2 and with COVID-19*
Darlan Laurício Matte, Flávio Maciel Dias de Andrade, Jocimar Avelar Martins, Bruno Prata Martinez, Marlus Karsten
Resumo
Neste documento apresentamos uma atualização do documento pioneiro da ASSOBRAFIR produzido no final do mês de janeiro de 2020 quando da disseminação do então chamado novo Betacoronavírus (NCoV-2019). Ao longo de menos de seis meses a realidade alterou radicalmente, o vírus passou a ser chamado de SARSCoV-2, a doença causada pelo vírus recebeu o nome de Coronavirus Disease 2019 (COVID-19) e o vírus passou a afetar a vida de todos os cidadãos do Mundo. Atualmente são mais de 60 mil mortes confirmadas no país e mais de 500 mil mortes no mundo. O presente documento traz uma visão geral sobre o vírus, sobre os sintomas da doença, faixa etária acometida, período de incubação, formas de tratamento, meios de disseminação, análise de letalidade, formas de prevenção da disseminação do vírus, enfrentamento aos casos suspeitos, e um breve ensaio da atuação do fisioterapeuta no tratamento do paciente com a COVID-19.
Palavras-chave
Abstract
In this document we present an update of the pioneering ASSOBRAFIR document produced at the end of January 2020, when the dissemination of the so-called new beta-coronavirus (NCoV-2019) was at its begging. Over less than six months, reality changed radically. The virus was renamed as SARS-CoV-2, the disease caused by the virus was named Coronavirus Disease 2019 (COVID-19) and the virus affected the life of an increasing number of people around the world. Currently, in Brazil there are more than 60 thousand confirmed deaths and more than 500 thousand deaths worldwide. This document focus on different topics related to the pandemic such as information about the virus, the incubation period, means of dissemination, ways of preventing the spread, symptoms caused by the disease, the main age range of infected patients, treatment options, COVID-19’s lethality, coping with suspected cases and a brief overview of the contribution of physiotherapy to treat patients with COVID-19.
Keywords
Referências
1. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 15-21 February; 395(10223): 514–523. doi:10.1016/S0140-6736(20)30154-9.
2.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497‐506. doi:10.1016/S0140-6736(20)30183-5. Correction in: Lancet. 2020 15-21 February; 395(10223): 496.
3.CDC Centers for Disease Control and Prevention. Coronavirus Disease 2019 Basics [Internet]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/faq.html#Coronavirus-Disease-2019-Basics
4.WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Feb 11]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
5.Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARSCoV-2. Nat Microbiol. 2020 Mar 2. PMID: 32123347
6.Worldometers. COVID-19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus/. Last updated: June 06, 2020.
7.Johns Hopkins University, Center for Systems Science and Engineering. Coronavirus COVID-19 global cases (JHU CSSE) [mapping dashboard] [cited 2020 June 06]. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
8.Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Pandemic (COVID-19) [Internet]. OurWorldInData.org; 2020. Available from: https://ourworldindata.org/coronavirus.
9.World Health Organization. Archived: WHO Timeline - COVID-19 [27 April 2020] [Internet]. Available from: https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19.
10.European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update – 12 March 2020. Stockholm: ECDC; 2020.
11.Chengdu-Expat. Coronavirus: Symptoms, Incubation Period and more [Internet]. Available from: https://chengdu-expat.com/wuhan-coronavirus-latest-updates/?from=timeline&isappinstalled=0
12. Chengdu-Expat. How to Keep Yourself Safe from Coronavirus [Internet]. Available from: https://chengdu-expat.com/how-to-keep-yourself-safe-from-coronavirus/
13.Medscape. Coronavirus Disease 2019 (COVID-19): A Global Crisis [Internet]. Available from: https://reference.medscape.com/slideshow/2019-novel-coronavirus-6012559#1
14. Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res. 2018;100:163‐188. Published online 2018 Feb 16. doi:10.1016/bs.aivir.2018.01.001
15.Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARSCoV-2. Nat Med. 2020 Mar 17;26(4):450‐452. doi:10.1038/s41591-020-0820-9
16.Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A Brief Overview [published online ahead of print, 2020 Mar 31]. Anesth Analg. 2020 Apr 20;10.1213/ANE.0000000000004845. doi:10.1213/ANE.0000000000004845
17.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020 28 March-3 April; 395(10229): 1054–1062. Published online 2020 Mar 11. doi: 10.1016/S0140-6736(20)30566-3
18.CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 10; 69(14): 422–426. Published online 2020 Apr 10. doi: 10.15585/mmwr.mm6914e4
19.Zhou B, She J, Wang Y, Ma X. The duration of viral shedding of discharged patients with severe COVID-19. Clin Infect Dis. 2020 Apr 17:ciaa451. Published online 2020 Apr 17. doi: 10.1093/cid/ciaa451
20.Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings[Internet] [Reviewed: March 19, 2020; cited 2020 June 07]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html.
21.Centers for Disease Control and Prevention. Coronavirus disease 2019 COVID-19: How to protect yourself. [Internet] [Reviewed: March 18, 2020; cited 2020 June 07]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.html.
22.ANVISA. Controle de Infecção em Serviços de Saúde [Internet] [cited 2020 June 07]. Available from: http://www.anvisa.gov.br/servicosaude/controle/publicacoes.htm.
23.ASSOBRAFIR. COVID-19. Posicionamentos [Internet] [cited 2020 June 07]. Available from: https://assobrafir.com.br/covid-19/.
24. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020; 46(6): 1099–1102. Published online 2020 Apr 14. doi: 10.1007/s00134-020-06033-2.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email